- Melrose Industries reported an adjusted pretax profit of GBP 248 million for the first half of 2025.
- Total pretax profit reached GBP 379 million.
- Adjusted operating profit was recorded at GBP 310 million.
- The company’s revenue for the period stood at GBP 1.72 billion.
- Net debt amounted to GBP 1.40 billion.
- Adjusted earnings per share (EPS) were 15.1 pence.
- Melrose Industries achieved a 29% improvement in profit compared to the previous period.
- The company experienced stronger cash flow despite facing supply chain and tariff disruptions.
- Market analysts have given Melrose 11 buy recommendations, 5 holds, and 1 sell.
A look at Melrose Industries Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 2 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Analysts at Smartkarma have assessed Melrose Industries PLC’s long-term outlook based on various factors. With a high score of 5 in Growth, the company is viewed favorably for its potential expansion and future earnings. Melrose Industries is acknowledged for its ability to grow and adapt within the competitive manufacturing sector.
On the other hand, Melrose Industries scored lower in Value, Dividend, Resilience, and Momentum. This suggests that while the company shows promise in growth, other areas like dividend payouts, stock value, and momentum may need attention for improvement. Overall, Melrose Industries, a global aerospace business with a focus on acquiring underperforming manufacturing businesses, seems to have a positive outlook for long-term growth based on Smartkarma’s analysis.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
